After data demonstrated Johnson and Johnson’s (J&J) one-dose vaccine offered significant protection against COVID-19 in monkeys, the pharmaceutical giant started human trials on July 30. The initial trial includes 1,000 adults in both…
New legislation, the Continuing Small Business Recovery and Paycheck Protection Program Act, has been introduced in the Senate. Under the umbrella of the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, this would…
A new treatment for individuals with leukocyte adhesion deficiency type 1 (LAD1) may also be beneficial for patients with Papillon-Lefèvre Syndrome, a genetic disorder associated with periodontitis.
Led by Regenstrief Institute research scientist Thankam Thyvalikakath, DMD, PhD, an associate professor and director of the dental informatics core at Indiana University School of Dentistry, the largest study to date of electronic dental…
An experimental investigation conducted at Kansas State University’s Biosecurity Research Institute found that SARS-CoV-2 is unable to replicate in three common types of mosquitoes, making it impossible for them to transmit the virus to…
Moderna and Pfizer have both begun large-scale clinical trials with 30,000 participants on their respective vaccines, with the hopes of obtaining regulatory approval and widespread distribution by the end of 2020. The Moderna and Pfizer…
With the need for simple, point-of-care testing that provides rapid results continuing to grow across the United States, scientists from the National Institutes of Health (NIH) recently introduced the Rapid Acceleration of Diagnostics…